Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau
A controversial medical trial in Guinea-Bissau will withhold hepatitis B vaccines from newborns for six weeks to study the effects. The trial has drawn criticism for ethical concerns, despite being supported by US health official Robert F. Kennedy Jr.
Why it matters
The trial raises significant questions about medical ethics, global health equity, and the influence of political figures on scientific research protocols.
A child receives a hepatitis B vaccine in Lomé, Togo, on 7 August 2015. Photograph: BSIP/Universal Images Group/Getty Images A child receives a hepatitis B vaccine in Lomé, Togo, on 7 August 2015. Photograph: BSIP/Universal Images Group/Getty Images Vaccines and immunisation Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau Recommended dose of hepatitis B vaccine will be withheld from thousands of newborns by Danish researchers
Prefer the Guardian on Google A controversial research trial that will withhold hepatitis B vaccines from some African newborns was given approval to move forward this week.
It is a central part of the vaccine vision for Robert F Kennedy Jr , the secretary of the US Department of Health and Human Services (HHS) and a longtime vaccine opponent.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in